Methods for Overcoming Chemoresistance in Head and Neck Squamous Cell Carcinoma: Keeping the Focus on Cancer Stem Cells, a Systematic Review
- PMID: 39272862
- PMCID: PMC11394389
- DOI: 10.3390/cancers16173004
Methods for Overcoming Chemoresistance in Head and Neck Squamous Cell Carcinoma: Keeping the Focus on Cancer Stem Cells, a Systematic Review
Abstract
According to the "cancer stem cell" (CSCs) theory, tumors are a diverse and expanding group of malignant cells that originate from a small number of CSCs. Despite treatment, these cells can still become active and proliferate, which can result in distant metastasis and local recurrences. A new paradigm in cancer treatment involves targeting both CSCs and the cancer cells in a tumor. This review aims to examine the literature on methods published to overcome chemoresistance due to the presence of CSCs in head and neck cancers. The review was registered with PROSPERO (ID# CRD42024512809). After Pub Med, Scopus, and WoS database searches, 31 relevant articles on oral squamous cell carcinoma (OSCC) were selected. Compounds that increased chemosensitivity by targeting CSCs in head and neck squamous cell carcinoma (HNSCC) were divided into (1) natural products, (2) adjuvant molecules to traditional chemotherapy, and (3) CSCs targeting patient-specific fresh biopsies for functional precision medicine.
Keywords: ChemoID; cancer stem cells; functional precision medicine; head and neck squamous cell carcinoma; natural products; oral squamous cells carcinoma.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Umbrella Review on Cancer Stem Cell in Oral and Head and Neck Squamous Cell Carcinoma.J Stem Cells Regen Med. 2023 Dec 31;19(2):29-33. doi: 10.46582/jsrm.1902007. eCollection 2023. J Stem Cells Regen Med. 2023. PMID: 38406617 Free PMC article. Review.
-
Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells.Mutat Res Genet Toxicol Environ Mutagen. 2019 Oct;846:503084. doi: 10.1016/j.mrgentox.2019.503084. Epub 2019 Aug 17. Mutat Res Genet Toxicol Environ Mutagen. 2019. PMID: 31585633
-
Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.J Biol Chem. 2016 May 13;291(20):10571-85. doi: 10.1074/jbc.M115.700021. Epub 2016 Mar 21. J Biol Chem. 2016. PMID: 27002147 Free PMC article.
-
Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing.Front Immunol. 2022 Nov 14;13:1050951. doi: 10.3389/fimmu.2022.1050951. eCollection 2022. Front Immunol. 2022. PMID: 36451812 Free PMC article.
-
Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges.Biomedicines. 2024 Sep 16;12(9):2111. doi: 10.3390/biomedicines12092111. Biomedicines. 2024. PMID: 39335624 Free PMC article. Review.
Cited by
-
PDLIM3 Regulates Migration and Invasion of Head and Neck Squamous Cell Carcinoma via YAP-Mediated Epithelial-Mesenchymal Transition.Int J Mol Sci. 2025 Mar 28;26(7):3147. doi: 10.3390/ijms26073147. Int J Mol Sci. 2025. PMID: 40243891 Free PMC article.
-
Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications.Pharmaceuticals (Basel). 2025 Jun 27;18(7):966. doi: 10.3390/ph18070966. Pharmaceuticals (Basel). 2025. PMID: 40732256 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources